FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula I
, in which R1 is H, Hal or CH3, X is Ar or Cyc, Ar is phenyl which is unsubstituted or mono-, di- or trisubstituted Hal, NO2, CN, A and/or [C(R2)2]pOR2, R2 is H or A, Cuc means cycloalkyl which contains 3, 4, 5, 6 or 7 C-atoms, A stands for unbranched or branched alkyl, which contains 1–6 C-atoms, where 1–5 H atoms can be replaced by F, Hal is F, Cl, Br or I, p means 0, 1, 2, 3 or 4, n means 1, 2 or 3, and their pharmaceutically acceptable solvates, salts, including mixtures thereof in all ratios. Method for the preparation of compounds of formula I and medicaments are also provided.
EFFECT: compounds of formula I are inhibitors of the tankyrase and can be used to treat and/or prevent malignant neoplasm, multiple sclerosis, cardiovascular diseases, central nervous system lesions and various forms of inflammation.
6 cl, 2 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS | 2013 |
|
RU2650107C2 |
PIPERIDINE UREA DERIVATIVES | 2014 |
|
RU2666894C2 |
OXOQUINAZOLINYL-BUTANAMIDE DERIVATIVES | 2014 |
|
RU2669393C2 |
IMIDAZOPYRAZINONE DERIVATIVES | 2014 |
|
RU2672885C2 |
PHTHALAZINE KETONE DERIVATIVE, METHOD OF OBTAINING THEREOF AND PHARMACEUTICAL APPLICATION | 2011 |
|
RU2564527C2 |
ANALOGUE OF INDOLOHEPTAMILOXIME AS A PARP INHIBITOR | 2020 |
|
RU2811039C2 |
(AZA-)ISOQUINOLINE DERIVATIVES | 2013 |
|
RU2654216C2 |
DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | 2009 |
|
RU2514937C2 |
2-ARYLBENZOFURANE-7-FORMAMIDE COMPOUNDS, METHOD FOR OBTAINING AND APPLICATION THEREOF | 2013 |
|
RU2583900C2 |
AMINO ACID DERIVATIVES, METHOD OF PRODUCING SAID DERIVATIVES, USE THEREOF AND PHARMACEUTICAL COMPOSITION | 2005 |
|
RU2379281C2 |
Authors
Dates
2018-08-07—Published
2014-05-30—Filed